Good morning and welcome to Equitable Holdings Third Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. I would now like to turn the call over to Jessica Baehr, Head of Investor Relations.

Thank you. Good morning and welcome to Equitable Holdings third quarter 2020 earnings call. Materials for today's call can be found on our website at ir.equitableholdings.com. Before we begin, I would like to note that some of the information we present today is forward-looking and subject to certain SEC rules and regulations regarding disclosure. Our results may materially differ from those expressed in or indicated by such forward-looking statements. So I'd like to refer you to the safe harbor language on Slide 2 of our presentation for additional information. Joining me on today's call is Mark Pearson, President and Chief Executive Officer of Equitable Holdings and Anders Malmstrom, our Chief Financial Officer. Also on the line is Ali Dibadj, AllianceBernstein's Head of Finance and Strategy. During this call, we will be discussing certain financial measures that are not based on Generally Accepted Accounting Principles, also known as non-GAAP measures. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures and related definitions may be found on the Investor Relations portion of our website, in our earnings release, slide presentation and financial supplement. I would now like to turn the call over to Mark and Anders for their prepared remarks.

Good morning and thank you all for joining us today. We are clearly living in interesting times with volatility and uncertainty unmatched by anything we've seen in our 161-year history. However, with our prudent risk philosophy and the relationships and insights we have, I have no doubt Equitable will continue to protect and support our clients, deliver strong financial results, and be a positive force for good in the communities in which we live. I'd like to begin this morning by sharing highlights from our third quarter, which you can see on Slide 3. Overall, I am pleased to report third quarter non-GAAP operating earnings per share of $1.24 per share or $1.31 per share, excluding the impacts of the annual actuarial assumption update, up 5% year-over-year. Assets under management are up 6% year-over-year to $746 billion, supported by net flows. Our strong performance this quarter continues to demonstrate our ability to adapt and deliver stable earnings. While uncertainty persists, we have seen new business activity trending upwards this quarter, now at 80% of normal levels, demonstrating the resiliency of our business model and the strength of our distribution. Offsetting the new business has been an improvement in client retention and top-up business such that net flows across the organization, including AB, remain positive and continue to support AUM growth. In terms of our balance sheet, we continue our prudent approach with interest rate assumptions on our GAAP reserves at 2.25%, the lowest among our peers in the industry. At Q3, we show healthy statutory RBC ratios and $2.3 billion of surplus cash at holdings. We believe maintaining financial flexibility and balance sheet strength are critical during these times. To this end, last week we announced a landmark transaction to reinsure a portion of our legacy variable annuity block to Venerable. As we shared last week, this transaction will reduce CTE98 tail risk by approximately 64% through the reinsurance of 13% of our in-force policies. This transaction validates our risk framework and unlocks $1.2 billion of statutory value and increases our RBC ratio by 60 percentage points. I think it is very important to understand that we were only able to transact with a credible partner like Venerable because of the work we've done in the last 10 years, including fund substitution, first dollar dynamic hedging, volatility tools and using our IPO to impose realistic reserve setting assumptions, both in respect of policyholder behavior and interest rates. Without any of these, the positive $300 million ceding commission we received would have been a very large payment in the other direction. Yes, there was a market for these books, but of course smart money will look first to the adequacy of the reserves. We also announced the acceleration of $500 million of share repurchases in 2021, incremental to the 50% to 60% payout ratio target which we continue to deliver on. Our focus remains on positioning our business for the future and enhancing long-term shareholder value as evidenced by the reinsurance transaction. Despite the fall in interest rates and the impact of the global pandemic, we remain on track to deliver on all guidance we gave at the time of the IPO in 2018. I'm pleased to announce that as a result of our strong expense focus, we achieved our $75 million productivity target ahead of schedule, and we expect incremental expense savings post-2020. Looking ahead, we will enter 2021 with good momentum and balance sheet strength to be further bolstered by the expected close of our legacy VA transaction in the second quarter, meaningful expense savings, and acceleration of shareholder returns. I will now pass it to Anders to give you some more details, including our annual assumption update, segment results, capital management and an update on our risk profile.

Thanks, Mark, and good morning. On Slide 4, I will briefly review our consolidated results for the third quarter before providing more detail on the outcome of our actuarial assumption update, segment results, capital management program and recent reinsurance transaction with Venerable. As Mark noted, non-GAAP operating earnings were $568 million for the third quarter or $1.24 per share. Excluding the limited impact from assumption updates in the current and prior year quarter, non-GAAP operating EPS increased by 5% primarily driven by share repurchases and strong net investment income. The increase in net investment income reflects higher asset balances and income from alternatives as well as the GA rebalance and the continuation of efforts to re-risk and de-risk our portfolio, including the sale of an additional $500 million of potential fallen angels as a net gain in the quarter. GAAP net loss was $779 million in the quarter and was primarily driven by non-economic impact from hedging and non-performance risk. AUM growth remained solid, supported by total company net inflows with assets up 6% year-over-year to $746 billion. Further, we continue to deliver on our return on equity target which improved 40 basis points from the prior-year quarter to 16.3%. Turning to Slide 5, I'd like to provide additional context and detail on our annual actuarial assumption review. As many of you know, we hedge to our full economic liabilities meaning we immunize the balance sheet to interest rates. If you recall, in light of persistently low and declining rates, we realigned our GAAP long-term interest rate assumptions early this year to better reflect economic realities. This change is reflected in our long-term assumption of current rate trading over 10 years to 2.25%, which remains the lowest among our peers by some margin. With this realignment completed in Q1, our third quarter assumption update was primarily focused on policyholder behavior, mortality and other assumptions across the business. As you can see from our results, the impact was fairly benign and is reflective of changes made to better align our assumptions to our economic framework. The total impact to non-GAAP operating earnings was a negative $31 million and the impact to net income was negative $58 million. This was primarily driven by a true-up to policies surrender assumptions for certain vintages in our Individual Retirement business, reflecting an additional year of experience. The impact to our other segments were largely immaterial. Moving on to the business segments. I will begin with Individual Retirement on Slide 6. Excluding assumption updates, operating earnings of $393 million were up 3% versus the prior-year quarter, primarily driven by the GA rebalance and higher alternatives income, as well as lower operating expenses. First-year premiums improved sequentially from the second quarter driven by an 18% increase in Structured Capital Strategies sales, reflecting the breadth and depth of our distribution. Importantly, nearly 85% of first-year premiums this quarter were driven by non-GMxB products as we continue to concentrate our focus toward higher growth, less capital-intensive products. While net flows were down from last quarter, we continue to favorably shift mix as outflows from our mature fixed rate block were partially offset by inflows on our current product offering. Further, as previously discussed, we also announced a transaction to reinsure a portion of our legacy VA block significantly de-risking the fixed rate GMxB block. Turning to Group Retirement on Slide 7. We reported operating earnings of $131 million, up 28% versus the prior-year quarter, excluding assumption updates in both periods. This was primarily driven by higher asset balances, the GA rebalance and an increase in alternatives income. Net outflows increased versus the prior year quarter, consistent with the seasonality we expect in the third quarter due to the K to 12 summer school break. Net outflows were partially offset by 3% growth in renewal contributions benefiting from our digital engagement initiatives. Account values increased by approximately $2.7 billion year-over-year due to market depreciation and continued net inflows over the trailing 12 months. Now turning to Investment Management and Research for AllianceBernstein on Slide 8. Overall AB delivered strong results with operating earnings of $104 million, up 12% year-over-year, primarily driven by higher base fees and higher average AUM and lower operating expenses. In the third quarter, AB generated $5.3 billion of net inflows, excluding expected low-fee AXA redemption of $2.2 billion. Net flows were strong across all three client channels led by another robust quarter for active equities in both retail and institutional. Further, AB reported gross sales of $29.3 billion, up $3 billion or 11% from a year ago, led by retail which has also had positive net flows in eight of the last nine quarters. Finally, AB's adjusted operating margin expanded by 220 basis points to 29.7% driven by lower operating expenses resulting from focused cost reduction initiatives, including the Nashville relocation.

Moving to Protection Solutions on Slide 9. We reported operating earnings of $48 million, excluding assumption updates, down from $104 million in the prior-year quarter, primarily due to the reestablishment of the PFBL reserve, as well as lower premiums. While Protection Solutions exited loss recognition following the assumption update this quarter, we expect ongoing earnings volatility due to the aforementioned PFBL reserve. We continue to experience lower than expected excess claims related to COVID-19. However, the PFBL reserve accrual more than offset the favorable mortality experience in the quarter. Even taking this into account, we believe our guidance of $30 million to $60 million in earnings impact for 100,000 excess US deaths remains appropriate. Gross written premiums decreased 10% versus the prior year quarter as strong growth in employee benefits was offset by declines in life premiums. We continue to see strong momentum in the employee benefits business, which benefited from strong persistency and generated year-over-year growth in gross premiums. Turning to Slide 10, I would like to highlight our strong capital and liquidity position that continues to give us confidence in the resiliency of our balance sheet despite the ongoing market uncertainty. Our balance sheet is well fortified as evidenced by a combined RBC ratio of approximately 430%, as well as holding company cash and liquid assets of $2.3 billion, well above our $500 million minimum target. This quarter we returned $176 million, including $76 million of quarterly cash dividends and $100 million of share repurchases. In the context of our 2020 capital management program, we have now returned $552 million to shareholders year-to-date or $952 million total, including the $400 million of repurchases accelerated into 2019. In terms of our debt to capital ratio, we ended the quarter at 23.9% in line with our target. We also raised $500 million in preferred stock in the quarter, capitalizing on attractive rates and favorable market conditions by further optimizing our capital structure and enhancing financial flexibility. Finally, we plan to accelerate $500 million of share repurchases in 2021 following the close of the legacy VA reinsurance transaction, incremental to our 50% to 60% payout ratio target that we continue to deliver on.

Turning to Slide 11, I think it's important to reiterate the significant impact the legacy VA reinsurance transaction will have on our risk profile. The deal allows us to meaningfully de-risk our balance sheet, best evidenced by the 64% reduction in CTE98 required assets that we hold to cover tail risk. That is a reduction of over $12 billion of reserves backing the policies being reinsured which further validates the level of reserves we hold against this liability. Importantly, we are able to achieve a reduction in our risk exposure by two-thirds by only reinsuring just one third of our most capital-intensive policies. All together, this transaction will result in an increase in our combined RBC ratio by approximately 60 RBC points. Against our third quarter RBC ratio of 430%, this equates to a pro forma RBC of approximately 490%, well above our minimum target of 375% to 400%. We firmly believe that this transaction further demonstrates the benefits of how we manage the business and illustrates clearly our ability to manage risk and generate long-term value. Further, we are pleased to see these points recognized in our conversations with rating agencies, investors, partners and other stakeholders as we continue to execute on opportunities to enhance our business. I will now turn it back to Mark for closing comments.

Thank you, Anders. Before taking your questions, I'd like to close by reiterating the key messages from the quarter. First, we have continued to demonstrate our ability to adapt to a wide range of economic scenarios and uncertainty while delivering strong results. Our balance sheet remains strong and will be bolstered further through our legacy VA transaction. And finally, looking ahead, we remain steadfast in our focus on growing our value-accretive businesses and delivering value for our clients and shareholders. With that, I will hand the call back to the operator to open the line for questions.

The first question comes from Nigel Dally with Morgan Stanley.

Great. Thanks. Good morning. I wanted to touch first on Group Retirement. Obviously, very strong quarter in terms of earnings that we saw come through this quarter. How should we think about the sustainability of that going forward? I think you mentioned alts as one of the drivers. Should that normalize down, just trying to get an indication as to on a go-forward basis what's a reasonable run rate there?

Thanks. Good morning, Nigel. I think I'll ask Anders to answer that question fully.

Good morning, Nigel. We are seeing continued strong momentum in the Group Retirement business, driven by consistent net inflows over the years. Additionally, we are witnessing good performance from client rebalancing in the channel, and I expect that to persist. Regarding alternatives, we have returned to normal levels, so we can anticipate standard returns moving forward.

Maybe if I just add something there, Anders, if I could. I mean it's been a really remarkable response from our teams there. Obviously, Group Retirement is predominantly made up of the business we write with teachers. Schools across the nation closed, the response of our teams in moving to a digital offer through teachers, through our advisors has been nothing short of remarkable. And we're really happy to see not only the response to the situation that we're in, but the business continues to go forward with very, very positive momentum. It's a really good response from the company.

Great. Thanks. And then just second on expenses. You stick to your initial target. You commented that there are additional meaningful expense savings in 2021 and beyond. Possible to put some dimensions around those savings and what kind of timing we're looking at as well as when it would actually flow through the bottom line?

We're not ready to provide a specific number yet, Nigel. We are currently working on it. As you can imagine, the teams have been fully focused on this VA transaction. However, in addition to the $75 million, we anticipate additional one-off sales this year due to COVID, reduced travel, and less entertaining. That is also coming in. We are also working on guidance that we'll share with you early in the New Year regarding the expected expense savings. The momentum is in our favor there as well.

Okay. Great. Thank you.

Thanks.

The next question comes from the line of Andrew Kligerman with Credit Suisse.

Hey. Good morning. I am trying to think a little bit about capital. So $2.3 billion of, by our estimate, excess capital at this stage in the game post the Venerable transaction in Q2, assuming that accelerated buyback which is terrific with $500 million maybe you invested in Venerable, you probably could be sitting with close to $3 billion of redeployable/excess capital. I am trying to get a sense of what's your priorities, assuming we can get beyond COVID, and let’s just assume that hopefully. What would your priorities be on capital, hold it, buy back more stock or are there big acquisitions out there that you'd like to do?

Thanks, Andrew and good morning. Look, we're very proud to be in such a strong capital position amid, as you say, global pandemic and historically low interest rates, which are always challenging for insurance companies. The reason we are in this position is because we managed an economic framework and we have, as Anders said in his opening comments, the most conservative interest rate assumption. So we've been able to secure a strong position, not by luck, but because of how we manage the balance sheet. In terms of capital deployment, we've returned nearly $3 billion to shareholders in the 2.5 years since the IPO. And I'm really, really proud that the team has been able to deliver to that 50% to 60% payout guidance ratio that we gave you. And this stability enables us to present the type of results that we have presented quarter after quarter. You're right. Following the close of the VA, we will accelerate an incremental $500 million there and we will return the remainder of excess capital. We're going to use it across a variety of options that we have. But we are very conscious that we are in the middle of a very uncertain time with the economy, very uncertain politically. Look at what's happening today. And of course, the COVID isn't over. So we feel it's proper and prudent that we do return capital in accordance with the guidance we gave. But we like where we are now. We're going to take a little bit of time to see what the best option is going forward.

Okay, Mark. There's no immediate priority regarding what to do with that cash, especially given the current unpredictable times. However, if we can return to normal, that would be a significant challenge.

I know. I don't want to be saying anything definitive now, Andrew, other than I am really proud of what our finance and strategy team have done to put us in this position of real strength with our balance sheet at a time when we really need it. So we're going through, as you say, really crazy times both across the economy and politically without quite knowing how that's landed yet. And of course, the COVID is ongoing. So we're in a good strong position and it's nice to have options, and we are going to keep that open as long as we can.

Okay. Fair enough. I want to ask one more question about the Individual Retirement segment. I noticed that product offering sales last year in the third quarter were $802 million, which decreased to $351 million in the third quarter of this year. As you mentioned earlier, first-year premiums were around 80% of the $2 billion last year. My question is, it seems that many of your competitors are de-risking and are looking to introduce buffered products, which we hear about frequently. Do you think you might continue to face pressure on sales, even as we eventually move past COVID-19, given the increasing competition?

Yeah. I mean you're right, Andrew, there is more competition on this product. I mean, firstly, we're very, very proud to have brought this new category to the market. It's great for retirees and investors to be in growth assets like this with some downside protection. It was part of that decade-long program I mentioned earlier, fund substitution getting out of those high-guarantee products, putting in win-win products for clients and for shareholders. And we had pretty much a free run at this, maybe three, four years before competitors started to come in. So good credit to our product development side. I think there's always two things, Andrew, on competition. One, products can be copied and if we have a winner we should not be surprised to see competitors come in and look to replicate that one. But what's harder for others to replicate is our distribution reach. I think the combination that really differentiates Equitable is that combination of having Equitable advisors, our unaffiliated sales force and a very, very strong third-party presence across banks, warehouses, and insurance companies. So we feel very good with the hand we have to play. But, yeah, I think it's too, a little bit more competition there.

Thanks much.

The next question comes from the line of Elyse Greenspan with Wells Fargo.

Hi. Thanks. Good morning. My first question, I guess, continuing on the capital discussion. You guys had spoken on numerous times about thinking about what to do with your AB stake. It sounded from the call last week that discussions have been focusing on the VA deal and then also with the uncertainty of COVID. But is it safe to assume that decisions there will be put off as you mentioned having some capital flexibility until things get back to normal or any kind of update you can just give us in terms of thought process around taking a decision on what to do with that stake in AB?

Thank you very much. You are correct. Our primary focus has been on de-risking our balance sheet through the VA reinsurance transaction, which has created significant value for our shareholders. We occasionally receive inquiries about AB. As you know, we hold a 65% stake in AB, which we established at the time of our IPO. We are very pleased with our investment in AB, as it aligns with our strategy of low capital intensity. Under the leadership of Seth and Ali, the business has performed exceptionally well, both in its traditional strategies and in alternative investments, with strong growth in private clients and in Asia. We do not see any urgent issues to address at this moment. There is no immediate need for action, but we will continue to evaluate the situation periodically. It hasn't been the appropriate time for any significant changes, and we will maintain efforts to ensure our balance sheet remains resilient. It is unlikely that we will make any substantial portfolio adjustments right now, as that would not be a wise decision.

Okay. Thanks. And then my other question was just a numbers question. Within corporate, you guys have been coming in better than the guide for the past couple of quarters. Anything one-off there or how should we just think about that segment, I guess, for the fourth quarter and then kind of toward 2021 as well?

Yes. So, look I think Corporate and Other have same pace and volatility between the quarters, but overall I think we gave the guidance that it will be for the full year somewhere around $350 million and I think that's exactly what I can confirm. There's nothing special there.

Okay. Thank you.

The next question comes from the line of Jimmy Bhullar with JPMorgan.

Hi. Good morning. I just had a couple of questions around the lines of the discussion with other analysts. First just on retirement. Your flows were negative and you mentioned it's partly because of seasonality, but deposits were down from last year as well. And wondering to what extent you feel that your business is susceptible to sort of the weaker economic environment and potential hardship withdrawals. If you've seen any of those given that the makeup is a little different than a typical corporate 401(k) business?

Hi, Jimmy. It's Mark. We did notice an increase in withdrawals last quarter, but I wouldn't characterize it as a significant trend. To be honest, Jimmy, the retirement provision is certainly linked to the economy, so I believe we are not completely shielded from its effects. However, what’s reassuring for us is that this year, the stability of our business has been strong. You should also consider that a substantial portion of our time flows and assets under management comes from our features business, which is likely less affected by economic conditions. It's improbable that the features will decline as much if the economy weakens, providing us with some protection against economic fluctuations. Anders, do you have anything to add?

Overall, I believe Group Retirement experiences some seasonality, and it's typically at its weakest during this time. However, we are seeing some very encouraging real-time initiatives. I want to highlight the increase in renewal contributions, which is a result of the outreach efforts from our team and the effectiveness of our digital tools, which have really gained traction. We observed a significant increase in Q2 that has carried over into Q3, and this bodes well for us. We are confident that we will achieve positive net sales for the entire year and will continue to perform well despite the current environment. While it is challenging to operate in a difficult environment, our team is highly engaged, and the rise in renewal contributions clearly indicates that our efforts are paying off.

Okay. And then on SCS, Mark mentioned sort of competing products by other insurers. As you're seeing competition pick up, is it more just on more sort of copycat type products by other companies or are you also being some of the newer competitors getting more aggressive on terms and conditions and that's having an impact on your sales for SCS?

I believe, as Mark mentioned, there is competition; however, we have seen growth in SCS from one quarter to the next. SCS remains strong, and with the introduction of new features like Dual Direction, we are continuously innovating, which is reflected in our quarter-over-quarter growth. This indicates that we have a solid product, and the rise in competitors shows there is demand from clients. Overall, it's a positive environment, and we are making significant progress.

Okay. Thank you.

The next question comes from the line of Suneet Kamath with Citi.

Thanks. Good morning. I wanted to start with protection solutions. You're highlighting the Employee Benefits segment a bit more in your commentary. So I'm just curious, I want to gauge your interest in using some of your capital to expand inorganically in that area to get scale as we've seen a number of other group benefits players do in recent years.

Suneet, hi. Good morning. It's Mark. I think we've said before that capital-light businesses like employee benefits, like wealth management and distribution would be an area of interest for us, providing they make economic sense. As you know, Suneet, they do sell still for very, very large multiples. So we had interest, but we would always be value-driven on something like this. So yeah, we'd be interested but please don't take that as a signal we are about to announce something.

Okay. And then I guess for AB, the 29.7% margin in the third quarter is pretty close to your original target of 30%. And I think for your comments, a lot of that was due to cost savings from the Nashville move. But as we think about the next leg up in that margin, are there business mix shifts either additions or subtractions that you're considering as you think about improving beyond 30%?

Suneet, I'm going to ask Ali, CFO from AB to answer that question. Over to you, Ali.

Thanks, Mark. Hey, Suneet. How are you? So look, I think as we plan AllianceBernstein in the future and where we're trying to go, there are clearly business mix shifts we're focusing on which should over time benefit both the fee rate, but also because of that the margin structure. So, for example, alternatives is a place where very much in collaboration with Equitable and their stated strategy of improving their yield, we're building an alternatives business, right. And over time, when that hits scale, margins should improve. That should help us continue to march forward in terms of our margin increasing. So, yes, there will be mix shifts across the board. Of course you have to remember and you've heard us talk about this on AllianceBernstein calls, on the Equitable calls to a certain extent as well that a lot of our margin is market-sensitive. So as the market continues to track higher, hopefully we continue to hope to reach that 30% margin over time.

And, Mark, would you be willing to invest some of that capital in inorganic opportunities at AB?

Yeah. Yes, Suneet, we already do. If you look over the past few years, I think the total of seed capital next year-end that AXA and Equitable will have put into AB is about $4 billion out of the general accounts. And AB today has done a fabulous job there built an business around about $30 billion of assets under management now. We see it as quite a win-win, Suneet. I mean we use a General Counsel leveraging internal leverage there, which is very nice. The general account policyholders are getting a higher yield and we are building a high multiple business for shareholders. So, yes, it is something that we have done and it's certainly something we look forward to doing more as the opportunities arise. I think it's one of the big synergies between Equitable and AllianceBernstein. In this regard, it's really good for AB to have a partnership with an insurance company like Equitable. I mean we give them $120 billion of assets to manage and they manage it very well for us, plus we can leverage seed capital out of the general account to give policyholder high returns and give additional returns to shareholders. So, yes, absolutely.

The next question comes from the line of Thomas Gallagher with Evercore.

Good morning. Just first a question on the VA risk transfer deal. Would you say we should view this as the likely permanent structure? Anders, as you said, this was reducing your tail risk by two-thirds. So clearly that's a major positive from a tail risk reduction standpoint. I'm just curious if you feel like this is kind of it and now you're properly positioned or would you consider doing additional risk transfer on, say, the rest of your legacy variable annuity business?

Yeah look - good morning, Tom. Look, as I said, I mean this is a different transaction that really reduces the risk by two-thirds only impacting one-thirds of the legacy and policies, I think it really reduces and changes the risk profile of the Company materially. It also validates really the reserving structure we have and that was always the requirement. When we talked previously about should we do a transaction or not because it really has to make sense for shareholders. With that transaction we showed that it's possible. So I think this looks to continue to be our premise. Right now we don't see a need to make a statement one way or the other. I think it just shows that we are managing the business really appropriately as validated by third-party investors and so we'll be really happy that we can do this massive risk transaction and that's a key milestone here and so then we take it from there.

I see this as a way to reduce tail risk while also highlighting the value and quality of the balance sheet. Is there also a long-term vision for reshaping your business, particularly considering the interest in moving into higher multiple sectors? This might involve significantly decreasing your Individual Retirement offerings while expanding your higher multiple businesses. I hope that makes my question clear.

Yeah. Look, I think it's absolutely right. I mean we tried to shape the business mix. That's not just at the total Company level but also look at the business mix shift we've done in Individual Retirement which is tremendous. I mean, we've showed that since May 2008 and now it's a massive risk shift within Individual Retirement. And we are very much committed to continue to be a large provider for Individual Retirement. So I wouldn't just look at the highest level of business mix. We really have to go deep. And I think that's what we're showing here, but it's obviously an important and continuous and focus for us.

I think this is an important point, Tom. I mean, obviously investors and analysts will have views on words like individual retirement and variable annuity. But if you look at our SCS product which is in those categories has a very different risk profile to some of the stuff that was written in 2005 to 2007. So, Anders' point is when we say value-accretive businesses which are low in capital intensity, we also mean within that category, because it is possible to design economically sound products that give Americans a very good access to growth assets too like the SCS, but enable us to perfectly match them on an ALM point of view and eliminate tail risk. So we will do both. We will look outside those sectors, but within as well.

That makes sense. My follow-up question is regarding your advising wealth and broker-dealer business and corporate segment. Does this generate much profit, if any? I understand you've expressed a desire to grow that business. Do you envision a possibility of it becoming a stand-alone segment that achieves profitability and is valued by the market at a higher level than anything within insurance? I'm just curious about your thoughts on this.

Yes, we do. Tom. It is profitable for us today. Have we given that number out before, Anders, how much it is? No. Okay. But it is profitable for us today, approaching $50 billion of assets under management in there. And obviously, we're not going to play in that sector unless we can make it significant. We're not here to do meaningless stuff. So we do see a path and we are already profitable on our wealth management side. Just not big enough yet to show it as a separate segment.

Your final question comes from the line of Ryan Krueger with KBW.

Mark, as a follow-up to your comments about SCS within Individual Retirement, can you give us a rough sense of if we look at the Individual Retirement segment maybe pro forma for the VA transaction. What percentage of earnings are driven by the SCS product at this point?

Anders, do you have that number?

I don't think we have the exact breakdown between SCS and the rest of the business there. It represents a significant portion, but we haven't disclosed it.

Okay. You mentioned the differences in managing variable annuities compared to some competitors. Policyholder behavior plays a significant role in that. Could you share some of your key assumptions regarding policyholder behavior in relation to the minimum floor requirements within NAIC variable annuity reform? Additionally, can you provide insight into how much lower your lapse rate assumption is compared to the requirements in the variable annuity capital requirement?

We don't disclose all the details, but we can take from our policyholders' behavior assumptions that they were validated by the transaction with Venerable. That's an important point. Additionally, when we look at the update we provided this quarter, the changes were very small. Considering our balances of $24 billion, we have only a few million dollars of variability. This demonstrates that our assumptions align well with the actual experience, which is what should guide us. However, we can't show how much differs from the minimum requirement. But based on our experience, we are very confident in this.

And the biggest shift across the line is the assumption on interest rates where as you know we immunize our balance sheet by using the forward rate. We use where rates are and looking at the capital position of the company and not some arbitrary reversion to a mean number. I mean that's a very, very significant factor in looking at the capital strength of the company.

Thank you.

That concludes today's conference. You may disconnect.